Second Genome Company
Second Genome offers a pipeline of microbiome modulators that impact infection, immunity and metabolic diseases.
Connections from
Technology:
Anti-infective Drugs
Headquarters:
San Francisco, California, United States
Funding Status:
Early Stage Venture
Investment Stage:
N/A
Founded Date:
2009
Number Of Exists:
N/A
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
PharmTech
Investor Type:
N/A